Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Correlation Between Serum Vitamin D Levels and the Incidence of Peripheral Neuropathy Among Multiple Myeloma Patients Who Have Previously Received Treatment With Bortezomib or Thalidomide

NCT01697839 is registered in ClinicalTrials.gov with Oncotherapeutics as lead sponsor.

NCT NCT01697839
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01697839 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Correlation Between Serum Vitamin D Levels and the Incidence of Peripheral Neuropathy Among Multiple Myeloma Patients Who Have Previously Received Treatment With Bortezomib or Thalidomide
Lead sponsor
Oncotherapeutics
Phase
Observational
Overall status
Completed
Start date
June 30, 2012
Completion date
August 31, 2015
Enrollment
110 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

multiple myeloma, peripheral neuropathy